Home  |  Contact
Due to maintenance work, this service will be unavailable Mon Feb 13 between 07:00 and 09:30 - CET. Apologies for the inconvenience.

Cellosaurus YSCCC (CVCL_3629)

[Text version]

Cell line name YSCCC
Synonyms CCC
Accession CVCL_3629
Resource Identification Initiative To cite this cell line use: YSCCC (RRID:CVCL_3629)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Population: Japanese.
Disease Cholangiocarcinoma (NCIt: C4436)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Derived from metastatic site: Ascites.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_QZ46 (YSCCC-G10)CVCL_QZ47 (YSCCC-G100)
Sex of cell Female
Age at sampling 70Y
Category Cancer cell line
STR profile Source(s): DepMap; RCB

Markers:
AmelogeninX
CSF1PO10,11
D3S135815,16
D5S81810,12
D7S82010,11
D8S117913,16
D13S31712
D16S53910,11
D18S5114
D21S1130
FGA22,23
Penta D9
Penta E5,18
TH017,9
TPOX11
vWA16,17

Run an STR similarity search on this cell line
Publications

PubMed=21451941; DOI=10.1007/s00534-011-0376-7
Sato J., Kimura T., Saito T., Anazawa T., Kenjo A., Sato Y., Tsuchiya T., Gotoh M.
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
J. Hepatobiliary Pancreat. Sci. 18:700-711(2011)

PubMed=21687941; DOI=10.3892/ijo.2011.1087
Kamigaki M., Sasaki T., Serikawa M., Inoue M., Kobayashi K., Itsuki H., Minami T., Yukutake M., Okazaki A., Ishigaki T., Ishii Y., Kosaka K., Chayama K.
Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells.
Int. J. Oncol. 39:561-568(2011)

PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442
Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C., Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K., Greninger P., McDermott U., Garnett M.J., Jenkins R.L., Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y., Goyal L., Ferrone C.R., Zhu A.X., Joung J.K., Shokat K.M., Benes C.H., Bardeesy N.
Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.
Cancer Discov. 6:727-739(2016)

PubMed=31077409; DOI=10.1002/hep.30704
Sittithumcharee G., Suppramote O., Vaeteewoottacharn K., Sirisuksakun C., Jamnongsong S., Laphanuwat P., Suntiparpluacha M., Matha A., Chusorn P., Buraphat P., Kakanaporn C., Charngkaew K., Silsirivanit A., Korphaisarn K., Limsrichamrern S., Tripatara P., Pairojkul C., Wongkham S., Sampattavanich S., Okada S., Jirawatnotai S.
Dependency of cholangiocarcinoma on cyclin D-dependent kinase activity.
Hepatology 70:1614-1630(2019)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

Cross-references
Cell line collections RCB; RCB1549
Cell line databases/resources CLO; CLO_0050859
Cell_Model_Passport; SIDM01824
DepMap; ACH-001864
Biological sample resources BioSample; SAMN03472100
Encyclopedic resources Wikidata; Q54995519
Entry history
Entry creation04-Apr-2012
Last entry update15-Dec-2022
Version number15